Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000552346 | SCV000628663 | likely benign | Neurofibromatosis, type 1 | 2024-07-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350191 | SCV002652301 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2021-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV003316683 | SCV004016401 | likely benign | Neurofibromatosis, familial spinal | 2023-07-07 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000552346 | SCV005880961 | benign | Neurofibromatosis, type 1 | 2025-02-01 | criteria provided, single submitter | clinical testing |